CompletedNot Applicable

Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion

South Korea512 participantsStarted 2019-08-26

Plain-language summary

The purpose of the present study was to evaluate the proportion of eyes that do not meet the eligibility criteria of clinical trials on neovascular AMD among the entire sample of eyes diagnosed with treatment-naïve neovascular AMD. The eligibility criteria of the VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet AMD (VIEW) studies, were used for this investigation.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with treatment-naïve, active neovascular AMD between January 2017 and December 2017. * Patients aged ≥ 50 years old * Patients who received intravitreal anti-VEGF injection after the diagnosis Exclusion Criteria: \- None

What they're measuring

The proportion of eyes that do not meet the eligibility criteria of clinical trials on neovascular AMD among the entire sample of eyes diagnosed with treatment-naïve neovascular AMD

Timeframe: Baseline

Trial details

NCT IDNCT04836143

SponsorKim's Eye Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-01-26

View on ClinicalTrials.gov More Age-related Macular Degeneration trials